I’ve heard (and watched) several interviews with the vivacious Elizabeth (Liz) Parrish. Recently I heard her twice on The Future Tech Podcast. I found the first interview to be very concise and therefore introductory for people not yet familiar with gene therapy as an emergent tool to treat biological aging (regenerative medicine). In 2015, Liz flew to Bogotá (Columbia) and... Read MoreAnti-Aging Gene Therapies—Elizabeth Parrish (CEO, BioViva)
In this eighth episode, Ben Hwang, Chairman & CEO of Profusa, provides an overview of injectable biosensors. He explains that the technology enables a model akin to getting a blood test every few seconds of our life (rather than only every few years when sick). He predicts that this “unlocked stream of biochemistry data” will become married to other data (e.g. our voice patterns) to provide a panoramic view of our health and wellbeing.
Lee: On today’s show, we have Ben Hwang, who is the Chairman and Chief Executive Officer of Profusa. From his early exposure as an undergraduate research fellow at the lab of Leroy Hood at Caltech, where the automated DNA sequencer was developed, to bringing cutting edge life science tools to the market at Life Technologies Corp, acquired by Thermo Fisher... Read MoreProfusa’ Ben Hwang on injectable biosensors
In this seventh episode, Nathan Price, Professor & Associate Director of the Institute for Systems Biology, explains the concept and aspiration of 'scientific wellness'. He predicts that it will become the dominant paradigm of 21st century healthcare. He explains ‘personal, dense, dynamic data clouds’ will enable both peak wellness and disease avoidance. Possibilities that China may leapfrog the United States.
Lee: Hello, Nathan. Welcome to the seventh episode of the Hyper Wellbeing podcast. Nathan: Lee, it’s great to be with you. Lee: Appreciate it. The last time I saw you was at Hyper Wellbeing 2016 where you gave a keynote. That was greatly appreciated. Nathan: It was a great meeting. Thanks for organizing. Lee: Nathan, can you do a favor... Read MoreISB’s Nathan Price on ‘scientific wellness’ as dominant paradigm of 21st century healthcare
In this sixth episode, Tommy Wood, CSO Nourish Balance Thrive, explains that the majority of modern disease is caused by our environment and as such, under our control. He shares his experience that A.I. coupled with ordinary blood tests, can inform us of changes we can make to protect/optimize our health, or when sick, lower the cost by predicting which further tests to conduct.
Lee: Hello, and welcome to the Hyper Wellbeing podcast, Tommy. Tommy: Oh, thanks for having me. Lee: Tommy, let’s just jump in here. You still look young, you’ve got a fantastic resume, or as the British would say, I think, curriculum vitae. Where is the motivation coming from? What’s your driving force? What’s the mission you’re on? Tommy: I guess... Read MoreNBT’s Tommy Wood on engineering sustained health using A.I. & standard blood chemistry (transcript)
In this fifth episode, Don Brown, CEO LifeOmic, explains the nomenclature shift from precision medicine to precision health, details the firm footing his company has in precision health, how it’s now extending another foot forwards into hyper wellbeing. Lots of app, lifestyle medicine, lifespan, healthspan and biological age quantification chat.
Lee: Hi, so you’re CEO of LifeOmic, a company which I have been tracking for some time. Could you be so kind as to introduce, to give a brief introduction to LifeOmic? Don: Yeah, I started LifeOmic almost two or so years ago. I went through a combined degree in the PhD program many years ago and ended up taking... Read MoreLifeOmic’ Don Brown on precision medicine vs precision health vs hyper wellbeing (transcript)